Quantcast
Home > Quotes > NURO
x
NURO

NeuroMetrix, Inc. Common Stock (NURO) Quote & Summary Data

$1.26
*  
0.02
1.61%
Get NURO Alerts
*Delayed - data as of Oct. 22, 2018 10:30 ET  -  Find a broker to begin trading NURO now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    NURO Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 1.23 / $ 1.25
1 Year Target
Today's High / Low
$ 1.26 / $ 1.23
Share Volume
16,882
50 Day Avg. Daily Volume
78,849
Previous Close
$ 1.24
52 Week High / Low
$ 2.96 / $ 1.111
Market Cap
9,279,948
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.42

Intraday Chart

Shares Traded

Share Volume:
16,882
50 Day Avg. Daily Volume:
78,849

Trading Range

The current last sale of $1.26 is 13.41% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 1.26 $ 2.96
 Low: $ 1.23 $ 1.111

Company Description (as filed with the SEC)

NeuroMetrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. Our business is fully integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. We derive revenues from the sale of medical devices and after-market consumable products and accessories. Our products are sold in the United States and selected overseas markets, and are cleared by the U.S. Food and Drug Administration, or FDA, and regulators in foreign jurisdictions where appropriate.  ... More ...  


Risk Grade

Where does NURO fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 1.25
Open Date:
Oct. 22, 2018
Close Price:
$ 1.24
Close Date:
Oct. 19, 2018

Consensus Recommendation

Analyst Info